Get started
Author

Taishi Harada

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
2015 · Keiichi Ota, Koichi Azuma, et al. · Clinical Cancer Research · 448
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer
2013 · Kyoko Okamura, Koichi Takayama, et al. · Lung Cancer · 242
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias
1998 · Masaharu Nakayama, Morimasa Wada, et al. · Blood · 174
Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis
2009 · Takanori Akagi, Takemasa Matsumoto, et al. · Respiratory Medicine · 137
PDF
Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer
2020 · Naoto Iwai, Takashi Okuda, et al. · Scientific Reports · 119
PDF
MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
2000 · Y Tada, M Wada, et al. · PubMed · 117
Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR‐mutated non‐small cell lung cancer
2019 · Tadaaki Yamada, Soichi Hirai, et al. · Cancer Medicine · 111
PDF
Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis
2012 · Kentaro Watanabe, Nobuhiko Nagata, et al. · Respiratory Investigation · 103
Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
2012 · Kyoko Okamura, Taishi Harada, et al. · Lung Cancer · 101
The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis
2014 · Taishi Harada, Yuji Yoshida, et al. · European Respiratory Review · 91
Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring EGFR mutations
2017 · Kentaro Tanaka, Kaname Nosaki, et al. · Oncotarget · 85
PDF
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)
2021 · Hiroyuki Yamaguchi, Kazushige Wakuda, et al. · Journal of Thoracic Oncology · 74
PDF
Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies
2019 · Yasuto Yoneshima, Kentaro Tanaka, et al. · Lung Cancer · 74
Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
2014 · Heyan Li, Koichi Takayama, et al. · Cancer Chemotherapy and Pharmacology · 71
PDF
Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells
1999 · Hitoshi Kusaba, Masaharu Nakayama, et al. · European Journal of Biochemistry · 67
Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non‐specific interstitial pneumonia
2012 · TAISHI HARADA, KENTARO WATANABE, et al. · Respirology · 63
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer
2017 · Kohei Otsubo, Kaname Nosaki, et al. · Cancer Science · 61
PDF
Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer
2011 · Taishi Harada, Yasushi Yatabe, et al. · Clinical Cancer Research · 61
PDF
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial
2023 · Yoshimasa Shiraishi, Junji Kishimoto, et al. · JAMA Oncology · 58
Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)
2017 · Eiji Iwama, Yasushi Goto, et al. · Journal of Thoracic Oncology · 54
Histological evolution of pleuroparenchymal fibroelastosis
2014 · Takako Hirota, Yuji Yoshida, et al. · Histopathology · 53
PDF
Sensitivity and kinase activity of epidermal growth factor receptor ( EGFR ) exon 19 and others to EGFR ‐tyrosine kinase inhibitors
2013 · Kazuto Furuyama, Taishi Harada, et al. · Cancer Science · 52
PDF
Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial
2021 · Kentaro Tanaka, Hajime Asahina, et al. · European Journal of Cancer · 50
Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non–small cell lung cancer
2017 · Noriko Hidaka, Eiji Iwama, et al. · Lung Cancer · 44
Epithelial–mesenchymal transition in human lungs with usual interstitial pneumonia: Quantitative immunohistochemistry
2009 · Taishi Harada, Kazuki Nabeshima, et al. · Pathology International · 43
Works count: 204
Citation count: 3,957
H-index: 33
I10-index: 81
Year
Topic
Type